Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2021 Nov;11(11):e2394.
doi: 10.1002/brb3.2394. Epub 2021 Oct 17.

The efficacy of vitamin B6 as an adjunctive therapy to lithium in improving the symptoms of acute mania in patients with bipolar disorder, type 1; a double-blind, randomized, placebo-controlled, clinical trial

Affiliations
Randomized Controlled Trial

The efficacy of vitamin B6 as an adjunctive therapy to lithium in improving the symptoms of acute mania in patients with bipolar disorder, type 1; a double-blind, randomized, placebo-controlled, clinical trial

Rahim Badrfam et al. Brain Behav. 2021 Nov.

Abstract

Objective: Vitamin B6 has been linked to a variety of probable roles, including anti-inflammatory, homocysteine-lowering, serotonin-regulating, and dopamine-lowering. In this study, we investigated the possible effect of vitamin B6 on bipolar disorder in manic episode with psychotic feature in a placebo-controlled double-blind clinical trial in a psychiatric hospital.

Methods: This study was performed on 50 patients who were equally divided into two groups (each group included 25 patients) using 80 mg of vitamin B6 daily or placebo. At the beginning and end of the study, they were evaluated for lab tests, inflammatory biomarkers and level of blood homocysteine. Also, at the baseline and in weeks 2, 4, and 8, they were evaluated based on the anthropometric measurements, score obtained from the Young Mania Questionnaire, Mini-Mental State Examination (MMSE), and the Pittsburgh Sleep Questionnaire.

Results: Accordingly, based on Yang Mania scoring scale, no significant difference was observed between the two groups receiving vitamin B6 and placebo (22.68 ± 5.39 vs. 21.80 ± 5.39 [p-value = .51]). Based on MMSE, significant improvement in cognitive status was obtained in group placebo compared to vitamin B6 group (25.24 ± 1.96 vs. 24.40 ± 3.25, respectively [p-value = .01]). At the Pittsburg scale (total, there was no statistically significant difference between the two groups receiving vitamin B6 and placebo (1.04 ± 0.20 vs. 0.48 ± 0.50 [p-value = .23]). Additionally, no significant difference was observed between the two groups regarding the anthropometric status.

Conclusions: According to this study, the daily dose of 80 mg of vitamin B6 for 8 weeks in patients with bipolar disorder in the manic episode with psychotic feature treated daily with lithium, was not associated with a significant improvement in mood status compared to the control-placebo group. It is recommended to perform similar studies in a multi-center manner with a larger sample size and longer duration.

Keywords: anthropology; bipolar disorder; homocysteine; lipids; mania; sleep; vitamin B6.

PubMed Disclaimer

Conflict of interest statement

There is no conflict of interest.

Figures

FIGURE 1
FIGURE 1
Flow diagram of the clinical trial of the efficacy of vitamin B6 as an adjunctive therapy in improving the symptoms of acute bipolar mania

References

    1. Aspy, D. J. , Madden, N. A. , & Delfabbro, P. (2018). Effects of vitamin B6 (pyridoxine) and a B complex preparation on dreaming and sleep. Perceptual and Motor Skills, 125(3), 451–462. - PubMed
    1. Atmaca, M. , Kuloglu, M. , Tezcan, E. , & Ustundag, B. (2002). Weight gain and serum leptin levels in patients on lithium treatment. Neuropsychobiology, 46(2), 67–69. 10.1159/000065414 - DOI - PubMed
    1. Baek, J. H. , Eisner, L. R. , & Nierenberg, A. A. (2014). Epidemiology and course of unipolar mania: Results from the national epidemiologic survey on alcohol and related conditions (NESARC). Depression and Anxiety, 31(9), 746–755. 10.1002/da.22261 - DOI - PubMed
    1. Belcastro, V. , D'Egidio, C. , Striano, P. , & Verrotti, A. (2013). Metabolic and endocrine effects of valproic acid chronic treatment. Epilepsy Research, 107(1–2), 1–8. 10.1016/j.eplepsyres.2013.08.016 - DOI - PubMed
    1. Brattström, L. , Israelsson, B. , Lindgärde, F. , & Hultberg, B. (1988). Higher total plasma homocysteine in vitamin B12 deficiency than in heterozygosity for homocystinuria due to cystathionine β‐synthase deficiency. Metabolism, 37(2), 175–178. 10.1016/S0026-0495(98)90014-2 - DOI - PubMed

Publication types